Pediatrix Medical Group, Inc. Proceeds and Excess Tax Benefit from Share-based Compensation
Pediatrix Medical Group, Inc. (MD) reported Proceeds and Excess Tax Benefit from Share-based Compensation of $1.70 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-17.
Discontinued › Notes › Compensation Related Costs
us-gaap:ProceedsAndExcessTaxBenefitFromSharebasedCompensation · last filed 2022-02-17
- Pediatrix Medical Group, Inc. proceeds and excess tax benefit from share-based compensation for fiscal 2021 was $1.70M.
- Pediatrix Medical Group, Inc. proceeds and excess tax benefit from share-based compensation for fiscal 2019 was $100.00K, a 97.30% decline from fiscal 2018.
- Pediatrix Medical Group, Inc. proceeds and excess tax benefit from share-based compensation for fiscal 2018 was $3.70M, a 22.92% decline from fiscal 2017.
- Pediatrix Medical Group, Inc. proceeds and excess tax benefit from share-based compensation for fiscal 2017 was $4.80M, a 2.13% increase from fiscal 2016.
| Period end | Proceeds and Excess Tax Benefit from Share-based Compensation 12 month |
|---|---|
| 2021-12-31 | $1.70M 10-K · filed 2022-02-17 |
| 2019-12-31 | $100.00K 10-K · filed 2022-02-17 |
| 2018-12-31 | $3.70M 10-K · filed 2021-02-18 |
| 2017-12-31 | $4.80M 10-K · filed 2020-02-20 |
| 2016-12-31 | $4.70M 10-K · filed 2019-02-14 |
| 2015-12-31 | $6.10M 10-K · filed 2018-02-14 |
| 2014-12-31 | $30.10M 10-K · filed 2017-02-10 |
| 2013-12-31 | $18.90M 10-K · filed 2016-02-11 |
| 2012-12-31 | $20.80M 10-K · filed 2015-02-09 |
| 2011-12-31 | $24.50M 10-K · filed 2014-02-12 |
| 2010-12-31 | $16.40M 10-K · filed 2013-02-15 |
| 2009-12-31 | $12.50M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Encompass Health Corp (EHC) | United States | $12.039B | 16.15 |